SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (694)8/19/2004 4:49:59 PM
From: tuck  Read Replies (1) of 3661
 
Clinical proteomics wannabe Power3, off 20% today, issued this cryptic PR after hours:

>>THE WOODLANDS, Texas, Aug. 19, 2004 (PRIMEZONE) -- Power3 Medical Products, Inc. (OTC BB:PWRM.OB - News), a leading proteomics company, has issued this press release to inform its shareholders and other interested parties that it has come to management's attention that there have been messages left on answering machines purporting to convey information about Power3 Medical Products. The Company is not a party to any of these activities, nor approves of them.

The Company believes that the recent volatility in the volume and stock price may be due to this activity. Power3 Medical refers investors and interested parties to the website at power3medical.com for a complete and accurate description of the business. Additionally, on the website you will find all authorized company press releases issued since May 18, 2004, as well as a link to the Securities and Exchange Commission's website where you can view all public filings made with the Securities and Exchange Commission.

Power3 Medical Products is a leading proteomics company engaged in the discovery of protein footprints, pathways, and mechanisms of diseases. The Company's patent pending technologies are being used to develop screening and diagnostic tests for the early detection and treatment of disease. The Company's identified protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer and neurodegenerative disease.<<

snip

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext